NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Drug firm Jubilant Life Sciences on Wednesday said it has received approval from the US health regulator for its 0.9% Sodium Chloride injection, used for diluting or dissolving drugs, in the American market. The company's subsidiary Jubilant HollisterStier LLC, has received abbreviated new drug application ( ANDA) approval for 0.9%…

news

Avista Pharma Solutions, Inc. has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Mass. This facility offers Microbiology and Analytical Chemistry testing services as well as Cleanroom services (supporting environmental monitoring, qualification and certification) and has been dedicated to providing these best-in-class services to the…

news

Spectrum Pharmaceuticals Inc Unit, teva pharmaceuticals usa, inc. Entered into settlement agreement to resolve patent litigation relating to Folotyn. Teva will be permitted to market generic version of folotyn in u.s. On december 1, 2022 or earlier under certain terms. Details of settlement are confidential, and parties will submit agreement…

news

Thunderbolt Inc acquired all rights to Astellas BAFF/APRIL Dual Antagonist program through an asset purchase agreement. Says Baxalta, Mayo Clinic and VPD will each contribute to development costs associated with program.   Source : reuters.com

news

France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc (MDVN.O) as early as Wednesday, according to people familiar with the matter. Sanofi has threatened to oust the board after Medivation rejected its unsolicited $9.3 billion…

news

Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain. The Indianapolis drugmaker said tanezumab, given by injection every eight…

news

Drug firm Suven Life Sciences has been granted a patent each by Australia, Eurasia, Israel and the us for a drug used in treatment of neuro-degenerative diseases. In a regulatory filing today, Suven Life said it has "secured product patents in Australia, Eurasia, Israel and the US to their New…

news

Almirall SA Signs through its Dallas based company Thermigen, an exclusive US strategic marketing collaboration agreement for Silhouette Instalift (TM) with Sinclair Pharma Plc. Thermigen has been initially granted with exclusive four-year distribution rights for US market until mid-2020.   Source : reuters.com

news

A preliminary review by the U.S. Food and Drug Administration questioned the usefulness of a combination diabetes drug made by Sanofi SA's and said it was unclear whether one component, lixisenatide, contributed to its benefit. The French drugmaker is seeking approval for lixisenatide alone and as part of a combination…

news

The DELHI High Court has asked pharma major PfizerBSE 0.60 % Ltd to withdraw stocks of its already imported drug Medrol, used to treat a wide range of inflammatory, allergic and immune disorders, six months before the expiry period of 60 months prescribed under the rules. Justice Rajiv Sahai Endlaw…